Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center.

Slides:



Advertisements
Similar presentations
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Advertisements

CONSERVATIVE CARE Douglas Koontz, M.D. Neurosurgery Specialists.
A Growing Problem…. We Will Discuss Prescription vs. OTC medications Alarming trends Myths about prescription drug abuse Specific medications of abuse.
Chronic Pain Management Elaine Wendt, MD. Pain is now “Fifth Vital Sign”
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.
Sublingual Buprenorphine and Pain
New Employee Orientation
New Employee Orientation (Insert name) County Health Department.
Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.
Tips for Pain Management Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health Management.
MaineCare & Opioid Treatment Where we are… How we got here… Where we are going… Kevin S. Flanigan, MD Medical Director Office of MaineCare Services.
Palliative Care in the Nursing Home. Objectives Develop an awareness of how a palliative care environment can be created. Recognize the need for changes.
The Prostate Net Pain management for patients and caregivers Biren Saraiya MD The Cancer Institute of New Jersey.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Pain Management at Stony Brook Medicine
1 Maine’s New Medicinal Marijuana Law Maine Association of Psychiatric Physicians April 30, 2010 Gordon H. Smith, Esq. Executive Vice President Maine Medical.
Responsible Pain Management Highlighting New Regulations of Indiana’s Medical Licensing Board and Best Practices for Patient Care Your Name Here.
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
DIVISION OF LICENSING & CERTIFICATION, BUREAU OF HEALTH SYSTEMS (BHS) - MDCH (517) Fax (517)
Medical Law and Ethics Lesson 3: Documentation and Regulations.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
For Pain or Not for Pain: Methadone Madness
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Opioid Compliance, Documentation, and Monitoring October 9, 2015.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Incidental Medical Services (IMS) Department of
Pain Management at Stony Brook Medicine
Medication Assisted Treatment
What Our Patients Look Like
Medications for Spine Pain
Gaston County Opioid Data
Current Concepts in Pain Management
Collaborative Practice Agreements
Georgia Nurse Protocol Agreement
Pain : Updates and Mandates
*Risk Evaluation and Mitigation Strategy
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
ISSUES IN OPIOID ASSESSMENT
Medication-Assisted Therapy at Coleman Profession Services
Ena Mahapatra, M.D., M.S., F.A.C.P
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Prescribing & Monitoring
Complete a legally valid prescription.
Controlled substance compliance
Barbara Allison-Bryan, MD
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Essentials of Good Pain Care: A Team-Based Approach
Pain Management at Stony Brook Medicine
The Silent Killer in America
Pain Management JEFFREY TAN HO, D.O.
Opiate misuse among our seniors
Presentation transcript:

Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center

 Effective December 15, 2013  Emergency rule that temporarily adds provisions under P.L (SEA246) regarding physicians prescribing opioids for chronic pain.  Under Title 844 Medical Licensing Board of Indiana

 Patients with chronic pain.  Chronic Pain is defined in this document as: A state in which pain persists beyond the usual course of an acute disease or healing of an injury, or that may or may not be associated with an acute or chronic pathologic process that causes continuous or intermittent pain over months or years.

 Patients with a terminal condition  Residents of a healthcare facility  Patients enrolled in a hospice program  Patients enrolled in an inpatient or outpatient palliative care program of a hospital

Patient has been prescribed: 1. More than 60 opioid containing pills a month; or 2. A morphine equivalent dose of more than 15 mg per day; for more than 3 consecutive months

 Evaluation and Risk stratification  Education of the patient as to risks and benefits of opioid therapy as well as expectations related to prescription requests and proper medication use  Continual monitoring and evaluation of therapy  DOCUMENTATION

 Indiana legislature passed a law, in compliance with a federal mandate for states, requiring the Indiana Medical Licensing Board to develop an emergency opioid prescribing rule.  Proliferation of “pill mills”  Prescription drug abuse has become a bigger problem than all other illicit street drugs  Pain has been treated as “5 th Vital Sign”

The US comprises 4% of the world’s population yet consumes 85% of the opioid medication. CDC

 Detox in Lake County Jail exploding from prescription drugs (10:1 RX to heroin)  Sheriff has established the High Intensity Drug Trafficking Task Force (Seized over $7M in RX drugs in 2013, already over that for 2014)  New trend: heroin cut with BZA  Wellbutrin and Gabapentin snorted together mimic heroin.

 17 th in US for RX drug deaths  Porter county #1 in IN for heroin deaths  In 2013, the OAG filed disciplinary complaints against 15 physicians for overprescribing pain medication; so far in 2014 they have already surpassed that number

 Procedures  Physical therapy/Aquatic therapy  Lifestyle changes  NSAID  Adjuvant medications  Psychological counseling  Alternative treatments

 Epidural Steroid Injections  Joint injections Steroid/Hyaluronate (Synvisc or Hyalgan)  Trigger Point Injections  Scar Neuroma Injections  Nerve Blocks (Chemical/Thermal)  Chemodenervation (Botox)

 Aquatic Therapy  Land Based  Home exercise program

 Weight loss  Smoking Cessation  Activity pacing  Back to work (work hardening/conditioning/restrictions)  Exercise

 OTC ibuprofen and naproxen  Prescription Mobic, Celebrex, Motrin, Diclofenac  Tylenol  Topical preparations Pennsaid, Voltaren Gel, Flector patches

 Antidepressants: Nortriptyline, Amitriptyline, Effexor, Cymbalta, Savella  Antiseizures: Gabapentin, Lyrica, Topamax, Lamitcal, Tegretol, Gralise  Muscle Relaxants: Baclofen, Tizanadine, Flexeril, Zanaflex, Robaxin, Skelaxin, (Exclude Soma)  Sedative/Antianxiety: Valium, Xanax, Klonopin  Topical: Lidoderm

 Evaluation is ALWAYS appropriate  Treat underlying issues that are closely related to pain such as depression and sexual abuse  Biofeedback  Relaxation/meditation  Imagery  Music therapy

 Acupuncture  Acupressure  Massage  Hypnosis

 Evaluation and risk stratification History and physical Obtain and review records from other providers Objective pain assessment tool Risk for substance abuse tool (SOAPP) Establish working diagnosis and tailor a treatment plan

 Risks/benefits and expectations Discuss alternative modalities to opioids Simple and clear explanation to help patient understand the key elements of their treatment plan Discuss with females ages with childbearing potential possible risks to the fetus

 Review and sign a treatment agreement which shall include at least the following: 1. Goals of treatment 2. Consent to drug testing*****(delayed until 1/1/15 due to ACLU lawsuit filed 1/8) 3. Physician prescribing policies which must include (at least) that the medication be taken as prescribed and not shared with anyone else.

4. A requirement that the patient inform the physician about any other controlled substances prescribed or taken. 5. Permission for random pill counts 6. Reasons that the opioid therapy may be discontinued or changed by the physician. *A copy of this agreement is to be retained in the patient’s chart.

 Periodic scheduled face to face visits Stable medication regime: at least every 4 months Changed medication regime: at least every 2 months During the visit, evaluate progress and compliance and set clear expectations along the way (such as participation in physical therapy)

 INSPECT At the outset of an opioid treatment plan and at least annually thereafter. Document in chart the consistency with physician’s knowledge of patient’s controlled substance history

 Drug Testing At the outset of opioid treatment plan and at least annually thereafter. Doesn’t specify serum, urine or saliva Must include confirmatory test results Inconsistencies or presence of illicits require review of treatment plan. Documentation of revised plan and discussion with patient must be recorded in chart.

 When a patient’s opioid dose reaches a morphine equivalent of 60 mg/day: Face to face review of treatment plan Consideration of referral to specialist If continuing therapy, there must be a revised assessment and plan for therapy Documented assessment of increased risk for adverse outcomes, including death.

 Short acting: Tylenol with codeine, Tramadol, hydrocodone, oxycodone, hydromorphone, Nucynta  Long acting: MS Contin, Fentanyl, Opana, Oxycontin, (Zohydro)  Methadone  Demerol  Intrathecal opioid therapy

 THE HOLY TRINITY Hydrocodone Muscle Relaxant (Soma) Benzodiazepine Red flag for DEA

 PRN vs. Scheduled  Treat flares and return to baseline  It’s OK to say “no.”  Be aware of trends and fads (Adderall)  Stay informed and aware

 Lake County Drug Task Force   Scott Nowland (219) x128   (Indiana AG office)  (Physicians for Responsible Opioid Prescribing)